These metabolic outcomes emerge from the mitigation of fatty acid oxidation, mediated by the obesity-associated gene and peroxisome proliferator-activated receptor alpha (PPARα) (Cheng et al. 2021). The gene discussed is PPARA; the disease is obesity disorder.